Part of our mission is to improve the health of humanity by making quality sequencing services both accessible and affordable. Joining the IDT AlignSM Preferred Sequencing Provider Program allows us to reach more NGS researchers looking to do just that.
Currently, our work includes partnering with Swift Biosciences (now part of IDT) to facilitate immediate needs related to the COVID-19 pandemic including:
- Comprehensive SARS-CoV-2 variant determination using next-generation sequencing (NGS)
- BTO qSanger for SARS-CoV-2 testing
- and more
Learn more about the Align program and our involvement in this press release from IDT.